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1. Introduction 
Colony stimulating factors (CSF) appear to be gly- 
coproteins [1] and have been prepared from many 
sources including serum and urine of both normal and 
leukemic individuals [2]. The biological activity of 
CSF is generally measured by its ability to promote 
the formation of granulocyte and/or mononuclear cell 
colonies in cultures of bone marrow cells suspended 
in either soft agar [3, 4] or methyl cellulose [5]. CSF 
has been shown to stimulate the in vitro incorporation 
of labeled precursors into DNA [6-8] ,  but colony 
formation cannot be explained simply in terms of a 
clonal proliferative model [8-11 ]. Moreover, morpho- 
logical observations and histochemical evidence have 
suggested that CSF promotes the in vitro differentia- 
tion and/or selection of granulocyte and mononuclear 
cell precursors in both normal and leukemic marrow 
cell populations [ 12-14]. 
Low concentrations of the thymidine analog BUdR 
inhibit the differentiation f specific ell types and 
prevent normal development in embryos [ 15-17]. It 
was of interest, herefore, to investigate what effect 
low concentrations of BUdR might have upon CSF- 
dependent colony formation. In this study, evidence 
is presented that CSF-dependent in vitro colony for- 
mation in cultures of mouse bone marrow cells is sig- 
nificantly inhibited by as little as 10 -7 M BUdR, and 
that BUdR appears to exert its inhibitory effect at a 
relatively early stage of colony formation. 
2. Materials and methods 
All isotopes were purchased from New England 
Nuclear Corp.: thymidine-3H-methyl, specific activity 
6.7 Ci/mmole; deoxycytidine-5-3H, specific activity 
30 Ci/mmole; 5-bromodeoxyuridine-6-3H, specific ac- 
tivity 25.2 Ci/mmole. Methylcellulose (4000 centi- 
pose) was obtained from Fisher Scientific. Fetal calf 
sera were the product of Flow Laboratories and North 
American Biologicals. Sera were kept frozen at -20°C 
in small batches to avoid repeated freezing and thaw- 
ing. All other reagents were of the highest purity com- 
mercially available. 
2.1. Preparation o f  CSF 
CSF was obtained from the urine of leukemic pa- 
tients admitted to Emory University Hospital. 
Twenty-four hour urines were collected in iced con- 
tainers to which liquid phenol (0.1%) had been added, 
and were then frozen. Urines from several patients 
were pooled and the protein from 6 liters was precipi- 
tated at 4°C by the addition of one volume of acetone. 
The precipitate was dissolved in 200 ml of H20 and 
then dialyzed against 5 liters of cold, distilled water 
for 72 hr (5 changes). The dialyzed material was cen- 
trifuged to remove any insoluble material and the re- 
suiting supernatant was passed through a column of 
Sephadex G-75 (5.5 X 55 cm, 4°C) which had been 
equilibrated in distilled water. The resulting active 
fractions were pooled, lyophilized and stored at -20°C 
2.2. Culture systems for CSF assay 
Both male and female C57 B1/6J mice (2-3 
months) were sacrificed by cervical dislocation at 8 -  
10 a.m. Marrow was expressed from each femur with 
2 ml of medium (100 parts McCoy's medium 5A 
(modified): 30 parts fetal calf serum). Generally, mar- 
row was pooled from at least one male and one female 
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mouse (1 femur each) for each experiment. Nucleated 
cells were counted using a Coulter counter. 
2.2.1. Colony forming activity 
Colony formation activity of CSF was assayed in 
agar containing medium using a double layer technique 
[18]. Feeder layers were prepared as follows: Double 
strength medium at 37°C was mixed with an equal vol- 
ume of 1% agar at 40°C. Two ml of this mixture were 
added to 35 mm Petri dishes (Falcon Plastics) contain- 
ing an aliquot of the CSF preparation to be assayed 
(0.3 ml or less). The contents of the dish were mixed, 
allowed to gel, and stored at 37°C under a humid at- 
mosphere of 7.5% CO 2 in air until inoculated with a 
marrow cell layer prepared in the following way: mar- 
row cells were added to medium containing 0.3% agar 
(37°C) to give a concentration of 2.5 X 104 cells per 
0.7 ml. This volume was pipetted onto each feeder lay- 
er and allowed to gel. The inoculated culture dishes 
were incubated for 7 days at 37°C in moist 7.5% CO 2 
in air at which time colonies were counted as de- 
scribed previously [19]. All cultures were done in du- 
plicate, and dose response curves were constructed us- 
ing a minimum of 3 CSF concentrations. The lines 
drawn through the data points were calculated by the 
method of least squares. Similar experiments were car- 
ried out in cultures containing 0.8% methylcellulose. 
2.2.2. DNA precursor incorporating activity 
CSF dependent incorporation of [3H]TdR or 
[3H]CdR was measured in liquid cultures or cultures 
containing methylcellulose (0.8%) as follows: Cells 
were added to single strength medium to give a con- 
centration of 105 or 106 cells per ml, and 1 ml aliquots 
were pipetted into 13 X 100 mm culture tubes contain- 
ing the CSF to be assayed (0.1 ml or less). The con- 
tents of the tubes were mixed and allowed to incubate 
at 37"C in an atmosphere of moist 7.5% CO 2 in air. 
At 48 hr, each tube received the indicated amount of 
[3H]TdR or [3H] CdR (specific activity 0.02 Ci/ 
mmole). After a 24 hr labeling period, 5 ml of the fol- 
lowing mixture were added to each tube: cold isotonic 
saline buffered with 10 mM sodium phosphate, pH 
7.4 (PBS) containing 0.5 mg of unlabeled TdR or CdR 
and approximately 105 fresh mouse bone marrow 
cells per mi (unnecessary when original inoculum was 
106 cells/ml). The tubes were centrifuged for 25 min 
(all centrifugations were carried out at 4°C and 2500 g), 
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Fig. 1. Colony-CSF dose response curves in cultures contain- 
ing different concentrations of BUdR. o - -o  Control, no 
BUdR; a - -a ,  10 -7 M; m--m, 10 -6 M;e - -e ,  10 -5 M. 
the supernatants were discarded, and the tubes were 
allowed to drain. After carefully wiping the lip of 
each tube with a Kimwipe, 0.4 ml of PBS was 
added. The cell pellet was dispersed using a Vortex 
mixer and 5 ml of cold 0.2 M perchloric acid (PCA) 
were added. After centrifuging for 25 min the super- 
natant was discarded. The pellet was then washed 3 
times each with 5 ml of 0.2 M PCA: centrifugation 
was for 10 min. Following the final wash, the tubes 
were allowed to drain, 1 ml of 0.2 M PCA was added, 
and hydrolysis was carried out in a boiling water bath 
for 20 rain. On cooling, 0.9 ml was counted in a 
Triton-toluene scintillation cocktail using a Beckman 
liquid scintillation spectrometer. Cultures were rou- 
tinely done in triplicate and dose response curves were 
obtained using a minimum of 3 CSF concentrations. 
Regression lines were drawn by the method of least 
squares. 
2.3. Isolation and centrifugation of DNA 
DNA was isolated by Sarkosyl-pronase treatment 
[20]. CsC1 gradient solutions were prepared by adding 
CsC1 to citrate-phosphate buffer (0.0625 M Na2HPO4, 
0.015 M Na 3 citrate, pH 7.2) containing 20-30/.tg 
DNA to achieve an average starting density of 1.70 
g]cm 3. Samples were overlayed with mineral oil and 
gradients were formed by centrifuging in a Spinco SW 
50.1 rotor for 48 hr at 35 000 rpm and 20°C using a 
Beckman L2-65B ultracentrifuge. Gradients were frac- 
tionated by piercing the bottom of the tubes and drip- 
ping fractions directly into counting vials. Samples 
were prepared for counting as described by Taylor 
et al. [20]. 
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Table 1 
Effect of time of addition of  BUdR (10 -6 M) on colony for- 
mation. 
Colony formation % of No. 
Time drug control 
No BUdR 10 -6 M BUdR 
0 5964 ± 590 173 ± 138 3 
24 5721 ± 629 154 ± 123 3 
48 5712 ± 415 1100 ± 704 23 
72 3714 ± 111 3462 ± 380 93 
* Colony formation is reported as the slope of the dose re- 
sponse curve -+ S.E. in units of colonies per 106 cells plated 
per ml CSF. Experiments were carried out using dual cham- 
ber tissue culture slides (Lab-Tek); one side served as the no. 
drug control and the other as the drug treated culture. Stan- 
dard errors were large for BUdR treated cultures at 0, 24 
and 48 hr owing to the small number of colonies. 
3. Results and discussion 
The effect of different concentrations of BUdR on 
colony-CSF dose response curves was determined in
soft agar, marrow cell cultures. These data are pre- 
sented in fig. 1 and show that 10 -5 M, 10 -6 M and 
10 -7 M BUdR inhibited colony formation 100%, 84% 
and 42% respectively. 
The following experiment was carried out in an at- 
tempt o learn if there was a critical time period in 
which BUdR was acting to inhibit CSF-dependent col- 
ony formation. BUdR (10 -6 M) was added to marrow 
cell cultures in methylcellulose after various times of 
preincubation i  the presence of different concentra- 
tions of CSF (table 1). These data indicated that the 
drug had essentially no effect on colony formation 
when added after 72 hr of preincubation. BUdR 
(10 -6 M) inhibited colony formation to approximate- 
ly the same extent in either agar or methylcellulose 
containing cultures. Control cultures to which medium 
(but no drug) was added showed a progressive de- 
crease in colony formation (table 1). At the present 
time, the reason for this decrease remains obscure, 
although it is not unreasonable to assume that mixing 
of the viscous culture medium following addition of a 
given material may lead to the disruption of incipient 
colonies. Nevertheless, it has been observed repeatedly 
that agitation of the cultures after 24 hr has a delete- 
rious effect on colony formation. 
The CSF-dependent incorporation of 3HoCdR into 
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Fig. 2. Effect of different concentrations of BUdR on CSF- 
dependent incorporation of [3H]CdR. e - -o ,  Control, no 
BUdR; a__z~, 10 -8 M; t~--t~, 10- 7 M; o - -o ,  10 -6 M. Cul- 
tures (106 cells) were labeled with 0.2 #Ci/ml of isotope for 
24 hr. The no. CSF cultures containing 0, 10 -6 M, 10 -7 M 
and 10 -8 M BUdR incorporated 725 ,502 ,713  and 701 cpm, 
respectively. 
marrow cell DNA was investigated in cultures contain- 
ing methylcellulose and to which different concentra- 
tions of BUdR had been added. The data shown in 
fig. 2 indicate that 10 -6 M BUdR inhibited incorpora- 
tion by about 50% whereas 10 -7 M and 10 -8 M 
BUdR each resulted in about a 20% inhibition as com- 
pared to the non-drug control. Thus it is evident hat 
a equivalent concentration f BUdR inhibited colony 
formation and precursor incorporation i to DNA to 
different degrees, its effect on colony formation being 
greater. These data lend additional support o the idea 
that non-proliferative aswell as proliferative vents 
are involved in the process of CSF-dependent in vitro 
colony formation [8-11 ]. 
To investigate whether BUdR was substituting for 
TdR under somewhat similar conditions to the experi- 
ments previously described, DNA was isolated from 
CSF-stimulated marrow cell cultures in liquid medium 
which had been labeled with either [3H] BUdR or 
[3H]TdR. The DNA was then subjected to equilibri- 
um isopycnic entrifugation i  buffered CsC1. The re- 
sults of such an experiment are shown in fig. 3, and 
indicate that BUdR does in fact substitute for TdR in 
the marrow cell DNA. DNA isolated from cultures 
labeled for 72 hr with 10 -6 M [3H]BUdR had a buoy. 
ant density indistinguishable from that of the unsub- 
stituted DNA. Labeling of the cultures for 24 hr using 
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Fig. 3. Cesium chloride-density gradient profiles of DNA iso- 
lated from 72 hr CSF-treated cultures (106 cells/ml). Cultures 
were labeled with 0.4 ~Ci/ml of isotope for (a) 72 hr with 
[3H]BUdR, specific activity 0.4 gCi/mM ( - - )  or (b) 24 hr 
with [3H]TdR ( . . . .  ) or [aH]BUdR ( ..... ), specific activity 
0.02 Ci/mM following a 48 br preincubation period. 
a concentration of [3H] BUdR of 2 × 10 -5  M resulted 
in sufficient substitution such that the DNA banded 
at a higher buoyant density. While these results might 
suggest that a rather limited substitution of the DNA 
by BUdR may be involved in the inhibition of  CSF- 
dependent colony formation, further data, obtained 
under strictly identical culture conditions, are needed 
to establish such a relationship. 
4. Conc lus ions  
These studies demonstrated that low concentra- 
tions of  BUdR were effective in interfering with some 
aspect of CSF-dependent in vitro colony formation in 
cultures of  mouse bone marrow cells. This interference 
appeared to be associated with an early event(s), and 
might be associated with the substitution of BUdR 
for TdR in the marrow cell DNA. The inhibitory ef- 
fect of BUdR was more pronounced on colony forma- 
tion than it was on precursor incorporation i to DNA 
[8-11 ]. Based on the known effects of BUdR on dif 
ferentiative events in other biological sy stems [ 15-17 ], 
we suggest that its effect in our system is of a similar 
nature. Further progress in understanding the mecha- 
nism of action of CSF and its role in proliferative and 
differentiative events of bone marrow cell develop- 
ment must await the availability of relatively homo- 
geneous fractions of marrow cells and more fully char- 
acterized preparations of CSF. 
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